Drug Sponsors

Biogen selects Cognizant’s SmartTrials Platform

Friday, July 1, 2016

Biogen has selected Cognizant‘s SmartTrials platform to aggregate and store clinical trial operational and patient data. Cambridge, Mass.-based Biogen has a portfolio of medicines to treat multiple sclerosis (MS) and is at the forefront of neurology research, working to develop novel therapies for conditions with few or no treatment options.

[Read More]

Richter acquires Finox Holding for $185.2M

Friday, July 1, 2016

Gedeon Richter has announced the acquisition of Finox Holding, a privately held Swiss biotech company focused on development and commercialization of innovative and cost effective products addressing female fertility. Gedeon Richter, headquartered in Budapest/Hungary, is a major pharmaceutical company in Central Eastern Europe, with an expanding direct presence in Western Europe. 

[Read More]

CenterWatch joins WIRB-Copernicus Group

Wednesday, June 22, 2016

WIRB-Copernicus Group (WCG), one of the world’s leading providers of solutions that measurably improve the quality and efficiency of clinical research, today announced its acquisition of CenterWatch, the leading provider of clinical trial industry news and information, and the addition of Kenneth A. Getz, CenterWatch founder and owner, to its board of directors.

[Read More]

Pfizer inks service agreements with Icon, Parexel

Friday, June 17, 2016

Icon, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, has signed a three-year agreement with Pfizer. Under the terms of the agreement, Pfizer has the right to extend the term for up to an additional two years. Financial details of the agreement were not disclosed.

[Read More]